Results 51 to 60 of about 238,483 (164)

Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma

Acta Ophthalmologica, EarlyView.
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel, Benjamin Aretz, Wolfgang Walz, Michael Petrak, Frank G. Holz, Raffael Liegl, Karl Mercieca, Constance Liegl   +7 more
wiley   +1 more source

Intraluminal stent removal after Paul glaucoma implant surgery: Intraocular pressure reduction and safety outcomes

Acta Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the outcomes of intraluminal stent removal from the Paul glaucoma implant (PGI). Methods A retrospective observational study of all cases undergoing PGI stent removal from August 2022 to August 2025 at a single Danish tertiary centre. Primary endpoints were intraocular pressure (IOP) and IOP‐lowering medications.
Anne Studsgaard, Iben Bach Damgaard, Niklas Telinius   +2 more
wiley   +1 more source

Therapeutic considerations in herpes-associated secondary glaucoma – clinical cases [PDF]

Pharmacia
Herpetic uveitis, most commonly caused by herpes simplex virus (HSV) and varicella-zoster virus (VZV), is a frequent cause of secondary glaucoma.
Stanislava Kostova, Nikolai Dakov, Maria Zankova   +2 more
doaj   +3 more sources

Neovascular glaucoma at a tertiary Centre in Finland, 2008–2024: A retrospective cohort study

Acta Ophthalmologica, EarlyView.
Abstract Purpose Neovascular glaucoma (NVG) is a refractory secondary glaucoma, yet longitudinal outcome data remain limited. This study reports its aetiologies, treatments and outcomes. Methods Patients with NVG were identified through electronic medical record review.
Gilbert Simons, Mikael von Fersen, Paula Summanen, Mika Harju   +3 more
wiley   +1 more source

A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma

, 2015
Purpose: To compare endoscopic cyclophotocoagulation (ECP) and the Ahmed drainage implant in the treatment of refractory glaucoma. Methods: Sixty-eight eyes of 68 patients with refractory glaucoma were prospectively assigned to either ECP or Ahmed tube ...
Carvalho, DM, Susanna, R, Lima, FE, Magacho, L, Avila, MP   +4 more
core   +1 more source

Australian and New Zealand Glaucoma Society (ANZGS) Consensus on Interventional Glaucoma

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Traditional reactive ‘wait and see’ approaches in glaucoma management often result in unacceptable rates of permanent vision loss. This consensus defines a proactive ‘interventional glaucoma’ framework tailored for the Australian and New Zealand healthcare context. Methods A modified Delphi consensus process was utilised, consisting
Graham A. Lee, Lance Liu, Ridia Lim, Rajiv Shah, Robert J. Casson, Keith R. Martin, Helen Danesh‐Meyer, Ashish Agar, Jennifer C. Fan Gaskin, Judy Y. Ku, Geoffrey Chan, Anna Galanopoulos, Shamira Perera   +12 more
wiley   +1 more source

Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma [PDF]

, 2012
Pur po se: To evaluate the safety and efficacy of transscleral diode laser cyclophotocoagulation (TSDLC) in advanced glaucoma refractory to medical or surgical treatment. Ma te ri al and Met hod: The data of subjects who were treated with TSDLC between
Banu Bozkurt, İsmail Doğru, Kerimoğlu, Hürkan, Mehmet Okka, Bozkurt, Banu, Öztürk Turgut, Banu, Kamis, Umit, Ozturk, Banu Turgut, Gülfidan Bitirgen, Doğru, İsmail, Kamış, Ümit, Hürkan Kerimoğlu, Bitirgen, Gülfidan, Ümit Kamış, Banu Turgut Öztürk, Okka, Mehmet   +15 more
core   +1 more source

Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]

, 2012
20.02.14 KB. Ok to add published verson to spiral, OA paper.A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case ...
Sallam, A, Gurbaxani, A, Taylor, SR, Lightman, S   +3 more
core   +1 more source

Ahmed and Baerveldt Glaucoma Drainage Devices in Childhood Glaucoma: A Meta-Analysis

, 2023
To evaluate the outcomes and safety of Ahmed glaucoma valve (AGV) and Baerveldt glaucoma implant (BGI) in childhood glaucoma. We performed a systematic literature review of publications from 1990-2022 in PubMed, EMBASE, ClinicalTrials.gov, Ovid MEDLINE ...
Shaarawy, Tarek, Hassan, Amr K, Chang, Ta C, Pakravan, Mohammad, Sallam, Ahmed B, Elhusseiny, Abdelrahman M, Chauhan, Muhammad Z, Azhari, Jamal O, Mansour, Munthir, VanderVeen, Deborah K, Oke, Isdin, Elkheniny, Fatmah D   +11 more
core   +4 more sources

Ocular Manifestations of Metabolic Syndrome: A Systemic Vascular Phenotype

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Context Metabolic syndrome (MetS) is defined by central obesity, insulin resistance, hypertension and dyslipidemia. MetS affects over one‐third of US adults. Beyond its cardiovascular burden, MetS has clinically relevant associations with ocular health and may contribute to a systemic vascular and neuro‐metabolic phenotype involving the retina,
Ron T. Varghese, Ansu A. John
wiley   +1 more source